WILMINGTON, Del.--(BUSINESS WIRE)--
Rigrodsky & Long, P.A.:
- Do you own shares of PROLOR Biotech, Inc. (NYSE MKT: PBTH)?
- Did you purchase any of your shares prior to April 24, 2013?
- Do you think the proposed buyout price is too low?
- Do you want to discuss your rights?
Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of PROLOR Biotech, Inc. (“PROLOR” or the “Company”) (NYSE MKT: PBTH) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by OPKO Health, Inc. (“OPKO”) (NYSE: OPK) in a transaction valued at approximately $480 million.
Click here to learn more: http://www.rigrodskylong.com/investigations/prolor-biotech-inc-pbth.
Under the terms of the proposal, public shareholders of PROLOR will receive 0.9951 shares of OPKO for each share of PROLOR they own. Based upon OPKO’s closing stock price of $7.06 on April 23, 2013, PROLOR shareholders would have received consideration valued at approximately $7.025 per share.
The investigation concerns whether PROLOR’s board of directors failed to adequately shop the Company and obtain the best possible value for PROLOR’s shareholders before entering into an agreement with OPKO. According to Yahoo! Finance, at least one analyst has set a price target for PROLOR stock at $12.00.
If you own the common stock of PROLOR and purchased your shares before April 24, 2013, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth Rigrodsky or Brian Long at Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, Delaware 19803, by telephone at (302) 295-5310, or Peter Allocco at Rigrodsky & Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City, New York 11530, by telephone at (888) 969-4242; by e-mail to firstname.lastname@example.org, or at: http://www.rigrodskylong.com/investigations/prolor-biotech-inc-pbth.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, on behalf of shareholders in states and federal courts throughout the United States.
Attorney advertising. Prior results do not guarantee a similar outcome.
- Health Care Industry